about
A novel mammalian expression system derived from components coordinating nicotine degradation in arthrobacter nicotinovorans pAO1.Therapeutic protein transduction of mammalian cells and mice by nucleic acid-free lentiviral nanoparticles.Synthetic therapeutic gene circuits in mammalian cellsA programmable synthetic lineage-control network that differentiates human IPSCs into glucose-sensitive insulin-secreting beta-like cellsLife after the synthetic cellThe NoRC complex mediates the heterochromatin formation and stability of silent rRNA genes and centromeric repeatsA synthetic low-frequency mammalian oscillatorNovel CNBP- and La-based translation control systems for mammalian cells.Identification of a novel proliferation-inducing determinant using lentiviral expression cloning.In vitro assays for anticancer drug discovery--a novel approach based on engineered mammalian cell lines.A novel mammalian cell-based approach for the discovery of anticancer drugs with reduced cytotoxicity on non-dividing cells.RepTAGs: universal tags for isolation and labeling of proteins, for labeling live mammalian cells and for drug discovery.Adeno-associated viral vectors engineered for macrolide-adjustable transgene expression in mammalian cells and miceA synthetic mammalian gene circuit reveals antituberculosis compounds.Smartphone-controlled optogenetically engineered cells enable semiautomatic glucose homeostasis in diabetic mice.Epigenetic engineering of ribosomal RNA genes enhances protein production.Hysteresis in a synthetic mammalian gene networkAntagonistic control of a dual-input mammalian gene switch by food additives.A designer cell-based histamine-specific human allergy profiler.An engineered mammalian band-pass network.A synthetic optogenetic transcription device enhances blood-glucose homeostasis in mice.Advanced modular self-inactivating lentiviral expression vectors for multigene interventions in mammalian cells and in vivo transduction.Synthetic immunology: modulating the human immune system.Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant.Artificial mammalian gene regulation networks-novel approaches for gene therapy and bioengineering.Conditional human VEGF-mediated vascularization in chicken embryos using a novel temperature-inducible gene regulation (TIGR) systemStreptomyces-derived quorum-sensing systems engineered for adjustable transgene expression in mammalian cells and mice.Synergies of microtissue design, viral transduction and adjustable transgene expression for regenerative medicine.A general design strategy for protein-responsive riboswitches in mammalian cells.Rational design of a small molecule-responsive intramer controlling transgene expression in mammalian cells.A synthetic time-delay circuit in mammalian cells and miceNovel theranostic agents for next-generation personalized medicine: small molecules, nanoparticles, and engineered mammalian cells.Phenylethyl butyrate enhances the potency of second-line drugs against clinical isolates of Mycobacterium tuberculosisMicroscale tissue engineering using gravity-enforced cell assembly.The food additive vanillic acid controls transgene expression in mammalian cells and miceSynthetic ecosystems based on airborne inter- and intrakingdom communication.Overexpression of YY1 increases the protein production in mammalian cells.Approaches for trigger-inducible viral transgene regulation in gene-based tissue engineering.Cosmetics-triggered percutaneous remote control of transgene expression in mice.Vitamin H-regulated transgene expression in mammalian cells.
P50
Q24816289-6781B081-B1C8-42EF-9CF9-CD7CDA9907AEQ25257819-2AA31CC8-3A53-41E4-BF6E-C0CF02EBEF1EQ26826954-FFF50A6A-FAF1-49A0-BCCB-D31CD3111852Q27320218-D58C2D05-723F-41C4-B47D-0844E26943AFQ28283177-A0D8198E-B732-4C1F-8AB4-F2F23C396D17Q28513482-A08D3617-F34E-417A-914F-C62A6C81B207Q30494239-4CD7C580-318A-45C4-952F-F923A01C06E5Q30870388-56E9D08F-5AEF-4661-9B66-0E2176CD0E7BQ30979937-761F8339-D12C-4EBA-9DB3-0A79C5939897Q31147285-D5501C7C-B396-4A70-B855-28374B85BB92Q33202549-A3E655FE-1240-431A-9C3E-44A5AA76D7FBQ33284225-39C99A9C-4501-4FCF-A908-A7695FE3DC94Q33305143-36469D46-851C-430F-8F19-316506E4F1E2Q33351251-9CFA94CE-30DC-4B6A-B7BC-789DBFA29D5DQ33454248-DD4AD28C-3B57-4049-95EC-CB5A8703820FQ33493413-81C7041D-B5F1-44DF-B4AD-F3FCC6B372BAQ33892242-4DA9C658-DFD0-41CB-9B1A-40F14595475DQ34044270-79E5C388-5773-4983-B354-0A97E50FA2FBQ34086352-59AC9B5E-BC43-4ED0-A90C-6381A0542ADAQ34189341-819713F3-E343-40BE-9175-3D822FF95F4CQ34195097-580CF1A4-C06C-43C8-B294-B9A6F0387ED4Q34329754-D1FE9FA1-0407-4BA8-B31F-FE9F78E5C73AQ34451645-2C148255-1C8F-4B30-996E-363A963DDAFFQ34563731-3D11FF2D-E35D-424A-8062-C49252DB32D1Q34762106-53FED723-3E8E-46E4-955E-FA9F0CBD38FFQ35109104-BCC73530-7F08-4645-9B4B-6D1BF77E8FE4Q35186186-2BC20480-A427-4D40-9111-1A7F46452809Q35216802-767511A2-2DA9-4E11-9A84-F5DBAF7562F1Q35302203-31173DC2-E029-402F-B0F6-88D3EF5DE332Q35617235-57108213-20C6-436E-ADF8-804C284802B1Q35633536-A7EB43D4-CB1A-421C-A946-1A67F850D1A0Q35657825-65FBD837-7DCC-441E-AA5F-8FE1F9261C70Q35689424-13BE6811-436B-4D09-960B-688B9610B875Q35707778-FB1FC779-2E4B-4799-BE3F-24668C312C3BQ35823680-46B84623-5189-49D9-B8C6-48812BF3D8D4Q35830251-4DA1C273-094E-4D72-A1B7-96EB231A42CEQ35873563-8B867FA1-2FA2-4131-91BE-7DCE83BFD945Q35908837-C89A0B76-13D7-4B12-B050-61ACA6D17139Q35961864-A031066B-DB6C-4133-B899-0FA0735CA677Q36082921-F92CD9C3-8E5B-4CB8-802E-8510F325A4EF
P50
subject
description
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Martin Fussenegger
@ast
Martin Fussenegger
@en
Martin Fussenegger
@es
Martin Fussenegger
@nl
type
label
Martin Fussenegger
@ast
Martin Fussenegger
@en
Martin Fussenegger
@es
Martin Fussenegger
@nl
prefLabel
Martin Fussenegger
@ast
Martin Fussenegger
@en
Martin Fussenegger
@es
Martin Fussenegger
@nl
P1006
P214
P1006
P106
P21
P214
P31
P496
0000-0001-8545-667X
P735
P7859
lccn-nb2004306168